Kyntra Bio (KYNB) Shares Outstanding (2014 - 2026)

Kyntra Bio has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $4.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.16% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (changed 0.16% YoY) and the FY2025 annual result came in at $4.0 million, changed 0.25% from the prior year.
• Shares Outstanding (Entity) was little changed at $4.0 million in Q1 2026 per KYNB's latest filing, from $4.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $4.0 million in Q1 2026 and troughed at $3.7 million in Q1 2022.
• A 5-year average of $3.9 million and a median of $4.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) gained 4.77% in 2023, then rose 0.16% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $3.8 million in 2022, then rose by 3.33% to $3.9 million in 2023, then rose by 3.71% to $4.0 million in 2024, then grew by 0.25% to $4.0 million in 2025, then increased by 0.03% to $4.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $4.0 million, $4.0 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.